SEATTLE--(BUSINESS WIRE)--Tasso, Inc., the leading provider of convenient, clinical-grade blood collection solutions, today announced that the U.S. Food and Drug Administration (FDA) has cleared its ...
CHICAGO--(BUSINESS WIRE)--MAIA Biotechnology, Inc. (NYSE American: MAIA), a clinical stage company developing telomere-targeting immunotherapies for cancer, today announced that the U.S. Food and Drug ...
Duty Of Disclosure Considerations For Medical Device Patent Applicants With Parallel FDA Submissions
Understanding the crucial overlaps between FDA disclosures and patent law is important for medical device innovators seeking ...
A smartphone-based app designed to deliver cognitive-behavioral therapy (CBT) to adults with type 2 diabetes received marketing approval as a class II medical device from the US Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback